Page Arthur B Amgen Inc Transaction History

Page Arthur B

$96 Million
Q1 2024

A detailed history of Page Arthur B transactions in Amgen Inc stock. As of the latest transaction made, Page Arthur B holds 860 shares of AMGN stock, worth $249,313. This represents 0.25% of its overall portfolio holdings.

Number of Shares

860

Previous 910 5.49%

Holding current value

$249,313

Previous $262,000 6.87%

% of portfolio

0.25%

Previous 0.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $13,443 - $16,228	-50 Reduced 5.49%	860 $244,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $23,013 - $25,961	-90 Reduced 9.0%	910 $262,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $11,289 - $13,760	-50 Reduced 4.76%	1,000 $241,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $22,446 - $25,315	-100 Reduced 8.7%	1,050 $237,000
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $80,748 - $89,859	-350 Reduced 23.33%	1,150 $280,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $9,944 - $11,380	-50 Reduced 3.23%	1,500 $337,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $106,135 - $124,350	-500 Reduced 24.39%	1,550 $330,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $29,197 - $32,392	-125 Reduced 5.75%	2,050 $499,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $72,120 - $84,045	-325 Reduced 13.0%	2,175 $541,000
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $23,465 - $26,095	-100 Reduced 3.85%	2,500 $636,000
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $39,562 - $48,548	-200 Reduced 7.14%	2,600 $613,000
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $46,653 - $61,875	-256 Reduced 8.38%	2,800 $567,000
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $68,494 - $88,038	-362 Reduced 10.59%	3,056 $737,000
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $62,157 - $74,477	-357 Reduced 9.46%	3,418 $661,000
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $25,005 - $29,311	-150 Reduced 3.82%	3,775 $695,000
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $27,130 - $30,582	-150 Reduced 3.68%	3,925 $746,000
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $50,954 - $57,444	-275 Reduced 6.32%	4,075 $844,000
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $41,512 - $46,627	-250 Reduced 5.43%	4,350 $803,000
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $16,943 - $19,800	-100 Reduced 2.13%	4,600 $784,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $29,538 - $33,003	-175 Reduced 3.59%	4,700 $817,000
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $815,538 - $931,125	4,875	4,875 $909,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Page Arthur B, based on Form 13F filings with the SEC.

News

Stay updated on Page Arthur B with notifications on news.

Account